Omnicell (OMCL) Non-Current Deferred Tax Liability (2012 - 2026)
Omnicell's (OMCL) quarterly Non-Current Deferred Tax Liability came in at $640000.0 in Q2 2026, down 51.26% year-over-year from $1.3 million in Q2 2025, and little changed quarter-over-quarter from $638000.0 in Q1 2026.
Analysis
Omnicell (OMCL) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Non-Current Deferred Tax Liability for 15 consecutive years, with $640000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 51.26% year-over-year to $640000.0 in Q2 2026; TTM through Jun 2026 was $640000.0, a 51.26% decrease from a year earlier, with the FY2025 full-year figure at $683000.0, down 99.18% from the prior year.
- Non-Current Deferred Tax Liability was $640000.0 for Q2 2026 at Omnicell, roughly flat from $638000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $98.9 million in Q4 2022 and troughed at $638000.0 in Q1 2026.
- A 5-year average of $19.5 million and a median of $1.5 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- The widest YoY moves for Non-Current Deferred Tax Liability: up 0.98% in 2025, down 99.18% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $98.9 million in 2022, then decreased by 12.82% to $86.3 million in 2023, then decreased by 2.93% to $83.7 million in 2024, then slumped by 99.18% to $683000.0 in 2025, then declined by 6.3% to $640000.0 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $640000.0 (Q2 2026), $638000.0 (Q1 2026), and $683000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 640,000.00 |
| Mar 31, 2026 | 638,000.00 |
| Dec 31, 2025 | 683,000.00 |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 83.73 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 86.26 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.56 Mn |
| Dec 31, 2022 | 98.94 Mn |
| Sep 30, 2022 | 16.14 Mn |
| Jun 30, 2022 | 23.91 Mn |
| Mar 31, 2022 | 28.17 Mn |
| Dec 31, 2021 | 110.28 Mn |
| Sep 30, 2021 | 53.31 Mn |